Celenex Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $100M

Celenex General Information

Description

Developer of gene therapy programs. The company's therapies use a similar approach to the SMA gene therapy. A modified adeno-associated virus, a workhorse gene therapy delivery tool, is loaded up with genetic instructions and infused into a patient's spinal fluid.

Contact Information

Formerly Known As
Graygenix
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 225 Arizona Avenue
  • Suite 200
  • Santa Monica, CA 90401
  • United States
Primary Industry
Buildings and Property
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 225 Arizona Avenue
  • Suite 200
  • Santa Monica, CA 90401
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Celenex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 20-Sep-2018 $100M Completed Stealth
1. Seed Round 01-Mar-2018 Completed Stealth
To view Celenex’s complete valuation and funding history, request access »

Celenex Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view Celenex’s complete cap table history, request access »

Celenex Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Anthem Venture Partners Venture Capital Minority
R1 Capital (Columbus) Venture Capital Minority
Wavemaker Partners Venture Capital Minority
To view Celenex’s complete investors history, request access »

Celenex FAQs

  • When was Celenex founded?

    Celenex was founded in 2017.

  • Where is Celenex headquartered?

    Celenex is headquartered in Santa Monica, CA.

  • What industry is Celenex in?

    Celenex’s primary industry is Buildings and Property.

  • Is Celenex a private or public company?

    Celenex is a Private company.

  • What is the current valuation of Celenex?

    The current valuation of Celenex is .

  • What is Celenex’s current revenue?

    The current revenue for Celenex is .

  • How much funding has Celenex raised over time?

    Celenex has raised $2M.

  • Who are Celenex’s investors?

    Anthem Venture Partners, R1 Capital (Columbus), and Wavemaker Partners have invested in Celenex.

  • When was Celenex acquired?

    Celenex was acquired on 20-Sep-2018.

  • Who acquired Celenex?

    Celenex was acquired by Amicus Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process